Picture of SymBio Pharmaceuticals logo

4582 — SymBio Pharmaceuticals News Story

0.000.00%
jp flag iconLast trade - 00:00
HealthcareHighly SpeculativeMicro CapSucker Stock

Table: SymBio Pharmaceuticals -6-MTH parent results

Aug 4 (Reuters)-  
             SymBio Pharmaceuticals Limited  
             PARENT-ONLY FINANCIAL HIGHLIGHTS  
     (in billions of yen unless specified)                 
                 6 months ended      6 months ended        Year to   
                Jun 30, 2016        Jun 30, 2015      Dec 31, 2016   
                   LATEST             YEAR-AGO           LATEST      
                   RESULTS             RESULTS          FORECAST     
  Sales             1.21               976 mln            2.34       
                 (+24.0 pct)         (+0.1 pct)        (+21.0 pct)   
  Operating     loss 819 mln        loss 647 mln        loss 2.78    
  Recurring       loss 1.18         loss 673 mln        loss 2.81    
  Net             loss 1.18         loss 676 mln        loss 2.82    
  EPS          loss 33.93 yen      loss 20.88 yen    loss 68.33 yen  
  Ann Div                                NIL               NIL       
  -Q2 div            NIL                 NIL                         
  -Q4 div                                NIL               NIL       
   
  NOTE - SymBio Pharmaceuticals Limited.  
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4582.T  
  ((Tokyo Headline News Desk +813 6441 1812))

Recent news on SymBio Pharmaceuticals

See all news